Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability.
EMBO Mol Med. 2018 Jun;10(6):e8289. doi: 10.15252/emmm.201708289.
EMBO Mol Med. 2018.
PMID: 29769258
Free PMC article.